Depuis 2001, l'AMA a subventionné des projets de recherche dans les secteurs suivants :
- Composés/Méthodes augmentant la croissance
- Composés/Méthodes augmentant le transport d'oxygène
- Stéroïdes anabolisants exogènes et endogènes
- Détection de substances/méthodes interdites : méthodologies classiques (chromatographique, immunologique et biochimique)
- Technologies génétiques et cellulaires appliquées au sport
- Pharmacologie des substances interdite
- Identification et/ou détection de nouvelles substances soupçonnées d'être potentiellement dopantes
Les résumés des projets de recherche en cours ainsi que les rapports des projets de recherche finalisés subventionnés par l'AMA depuis 2001 peuvent être consultés ci-dessous (en anglais).
ACCEPTÉ EN 2020 |
---|
Studies of glucocorticoids after oral administration: evaluation of reporting levels and washout periods
|
ACCEPTÉ EN 2019 |
---|
Administration study of black market Follistatins (FS-344, FS-315) |
New markers of steroid profile in blood: Differentiating testosterone administration from (simultaneous) ethanol consumption (acronym: SPOLBlood) |
Bis-Conjugates in the Endogenous Profile of Steroids (BICEPS II) |
Are poultry and eggs a source of minute amounts of clomiphene in doping control samples |
Cobalt quantification from erythrocytes and urine: Complementation of the ABP and definition of contributions by Vitamin B12-derived cobalt |
Simplified testing procedure for new potentially performance enhancing peptide hormones
Mario Thevis, Andreas Thomas / German Sport University Cologne, Germany |
Detection of doping with Myostatin-Propeptide in human urine and blood |
Increasing the sensitivity of GC-QTOF screening by using chemical ionization |
Dried microsamples: multi-matrix, long-term stability study of doping-relevant peptides
Laura Mercolini et al. / University of Bologna, Italy |
Physiological and biological longitudinal follow-up of elite and amateur athletes: a study of confounding factors for the ABP |
Evaluation of DNA mixture detection in Dried Blood Spots as a detection method for homologous transfusion |
Phase-II metabolites as target biomarkers in doping analysis – part 2: Biotechnological generation of sulfoconjugate reference material by fission yeast technology Maria Kristina Parr et al., / Freie Universität Berlin, Allemagne |
Evaluation of different off-line immunocapture techniques for efficient purification of large peptides in human urine Monica Mazzarino, Francesco Botrè, Xavier de la Torre / Federazione Medico Sportiva Italiana, Italie |
Improving detection of the confounding factor dutasteride Monica Mazzarino, Francesco Botrè, Xavier de la Torre / Federazione Medico Sportiva Italiana, Italie |
Is tramadol a Performance Enhancing Drug? Alexis Mauger and Trudy Thomas / University of Kent, Royaume-Uni - Paul Hayden / Medway Maritime Hospital, Royaume-uni |
Extending the steroidal module in DBS: Inclusion of direct and indirect markers of AAS abuse Monica Mazzarino, Francesco Botrè, Xavier de la Torre / Federazione Medico Sportiva Italiana, Italie
|
Rosa Ventura, Élida Alechaga Silva, Núria Monfort Mercader, Lorena Garrostas Carreño, Sergi Coll Camenforte / Doping Control Research Group, Fundació IMIM, Barcelone, Espagne - Masato Okano, Shinji Kageyama / Anti-Doping Laboratory, LSI Medience Corporation, Tokyo, Japon - Ana Maria Aldea Perona, Julian Andres Mateus Rodriguez / Clinical Research Unit, Hospital del Mar Medical Research Institute, Barcelone, Espagne |
Ingunn Riise Hullstein, Yvette Dehnes / Norwegian Doping Control Laboratory, Norvège - Guro Forsdahl / University of Tromsø The Arctic University of Norway
|